Wolbachia stimulates immune gene expression and inhibits plasmodium development in Anopheles gambiae by Kambris, Zakaria et al.
Wolbachia Stimulates Immune Gene Expression and
Inhibits Plasmodium Development in Anopheles
gambiae
Zakaria Kambris1, Andrew M. Blagborough2, Sofia B. Pinto1, Marcus S. C. Blagrove1, H. Charles J.
Godfray1, Robert E. Sinden2, Steven P. Sinkins1*
1University of Oxford, Department of Zoology and Peter Medawar Building for Pathogen Research, Oxford, United Kingdom, 2 Imperial College London, Sir Alexander
Fleming Building, South Kensington, London, United Kingdom
Abstract
The over-replicating wMelPop strain of the endosymbiont Wolbachia pipientis has recently been shown to be capable of
inducing immune upregulation and inhibition of pathogen transmission in Aedes aegypti mosquitoes. In order to examine
whether comparable effects would be seen in the malaria vector Anopheles gambiae, transient somatic infections of
wMelPop were created by intrathoracic inoculation. Upregulation of six selected immune genes was observed compared to
controls, at least two of which (LRIM1 and TEP1) influence the development of malaria parasites. A stably infected An.
gambiae cell line also showed increased expression of malaria-related immune genes. Highly significant reductions in
Plasmodium infection intensity were observed in the wMelPop-infected cohort, and using gene knockdown, evidence for
the role of TEP1 in this phenotype was obtained. Comparing the levels of upregulation in somatic and stably inherited
wMelPop infections in Ae. aegypti revealed that levels of upregulation were lower in the somatic infections than in the stably
transinfected line; inhibition of development of Brugia filarial nematodes was nevertheless observed in the somatic
wMelPop infected females. Thus we consider that the effects observed in An. gambiae are also likely to be more pronounced
if stably inherited wMelPop transinfections can be created, and that somatic infections of Wolbachia provide a useful model
for examining effects on pathogen development or dissemination. The data are discussed with respect to the comparative
effects on malaria vectorial capacity of life shortening and direct inhibition of Plasmodium development that can be
produced by Wolbachia.
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Introduction
Wolbachia pipientis is an intracellular maternally inherited
bacterial symbiont of invertebrates that is very common in insects,
including a number of mosquito species [1,2]. It can manipulate
host reproduction in several ways, including cytoplasmic incom-
patibility (CI), whereby certain crosses are rendered effectively
sterile. Females that are uninfected produce infertile eggs when
they mate with males that carry Wolbachia, while there is a ‘rescue’
effect in Wolbachia-infected embryos such that infected females can
reproduce successfully with any males. Therefore uninfected
females suffer a frequency-dependent reproductive disadvantage.
Wolbachia is able to rapidly invade populations using this powerful
mechanism [3–5].
A strain of Wolbachia called wMelPop has been identified that
over-replicates in somatic tissues and roughly halves the lifespan of
laboratory Drosophila melanogaster [6]. A transinfection of wMelPop
from Drosophila into the mosquito Aedes aegypti also leads to a
similarly shortened lifespan in the lab, as well as inducing strong
CI, which has made it a very promising candidate for the
development of new strategies for controlling mosquito-borne
diseases [7]. All mosquito-borne pathogens require an extrinsic
incubation period before they can be transmitted that is relatively
long (,9 days for malaria) compared to mean mosquito lifespan in
the field; therefore, a reduction in the number of old individuals in
the population will reduce disease transmission [8–11].
We recently found that the presence of wMelPop also produces
a major upregulation of a large number of immune genes in Ae.
aegypti and inhibits the development of filarial nematode worm
parasites [12]. We hypothesized that the two effects are
functionally related – higher levels of immune effectors in
wMelPop-infected mosquitoes render them better able to kill
parasites [12]. Homologs of some of the Ae. aegypti genes that are
upregulated in the presence of wMelPop have been previously
shown to have the ability to regulate development of Plasmodium
parasites in Anopheles, for example a transgene encoding cecropin-
A/a synthetic cecropin-B of Hyalophora cecropia; the NF-kB-like
transcription factor Rel2 controlling the Imd pathway; and TEP
(Thioester containing) opsonization proteins [13–20]. It has
recently been shown that the wMelPop-infected Ae. aegypti line
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has impaired ability to transmit an avian malaria, Plasmodium
gallinaceum [21]. It is possible that these effects of wMelPop could
be particular to the Ae. aegypti transinfection; however, if
comparable upregulation of orthologous immune genes, and
inhibition of Plasmodium development are also seen in the
important Anopheles vectors of human malaria, it may provide a
stimulus to the development of new Wolbachia-based malaria
control strategies.
To address this question we used Anopheles gambiae, the most
important vector of malaria in Africa, which like Ae. aegypti is not
naturally infected with Wolbachia. The creation of stably inherited
lines of An. gambiae is likely to require a long period of
microinjection and selection, as had to be performed for Ae.
aegypti [7]. However, in advance of the successful creation of an An.
gambiae stable transinfection, the effects of the presence of
wMelPop on immunity and malaria transmission can be tested
using an established wMelPop-infected An. gambiae cell line [22]
and the ability to create somatic lifetime infections of Wolbachia in
adult female mosquitoes by intrathoracic inoculation [23,24]. The
wMelPop strain forms disseminated somatic infections in its
natural Drosophila host [6], in common with some but not all
Wolbachia strains [25]. Given that a) Plasmodium parasites will travel
solely through somatic tissues on their journey to the salivary
glands, and b) that many of the known antimalarial immune
effectors are humoral/systemic, we consider that the creation of
somatic infections of Wolbachia via adult inoculation represents a
useful model for stably inherited germline-associated infections. To
examine this hypothesis further, we also created somatic wMelPop
infections in Ae. aegypti, in order to compare the magnitude of the
effects on mosquito immunity and filarial nematode parasite
development with those observed in the stably wMelPop-
transinfected line.
Results
Immune gene expression in An. gambiae
Given that a stable wMelPop infection of An. gambiae does not
yet exist, it was necessary to create transient somatic infections by
intrathoracic innoculation with purified Wolbachia. RNA from
these transinfected females was then tested for expression levels of
six immune genes, and upregulation of all these genes was
observed compared to buffer injected and E. coli - injected controls
(Figure 1). Of these genes, LRIM1 and TEP1 (whose products have
been shown to interact in the opsonisation response) have
previously been shown to have an important inhibitory or
antagonistic effect on Plasmodium development [18–20]. Impor-
tantly, injected mosquitoes were left for eight days before
Plasmodium challenge or qRT-PCR, and therefore the pulse of
immune gene upregulation caused by the injury itself or by the E.
coli challenge would be expected to have already passed [15].
The wMelPop infected cell line MOS55 [22] showed upregula-
tion of all six selected immune genes compared to an uninfected
cell line created by tetracycline curing of infected MOS55
(Figure 2). These data add confidence to the hypothesis that it is
the presence of wMelPop itself that is inducing immune gene
upregulation, and by extension Plasmodium inhibition, and that
these effects are not artefacts of the intrathoracic injection process.
The degree of upregulation was different for some genes in the cell
line than observed for the somatic in vivo transinfection. However
these differences would be expected given that many immune
genes are primarily expressed in particular cell types/organs in
adult mosquitoes, such as the fat body cells or in the case of TEP1,
Figure 1. Immune gene expression in An. gambiae somatically infected with wMelPop. The expression of six immune genes were analyzed
by qRT-PCR: leucine-rich repeat immune protein, LRIM1; thioester-containing protein, TEP1; cecropin, CEC1; defensin, DEF1; C-type lectin, CTL4; and
clip-domain serine protease, CLIPB3. Adult An. gambiae females were injected with E. coli, wMelPop or the buffer alone, 2–3 days post-eclosion, and
RNA was extracted from these adults eight days after injection. Expression was normalized to non-injected adult females of the same age from the
same colony. Error bars show the SEM of three biological replicates, each containing eight adult females (total of 24 mosquitoes per condition).
doi:10.1371/journal.ppat.1001143.g001
Author Summary
Malaria is one of the world’s most devastating diseases,
particularly in Africa, and new control strategies are
desperately needed. Here we show that the presence of
Wolbachia bacteria inhibits the development of a malaria
parasite in the most important Anopheles mosquito
species of Africa. In addition we show that the presence
of Wolbachia results in the switching on of immune genes
that are known to affect development of many species of
malaria parasite. When added to the lifespan-shortening
effects of this particular strain of Wolbachia, and the
general ability of Wolbachia to spread through insect
populations, our study provides a stimulus for the
development of Wolbachia-based malaria control meth-
ods. It also provides new insights into the wide range of
effects of Wolbachia in insects.
Wolbachia and Malaria
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the haemocytes [18], and the cellular composition of this larval-
derived cell line is unknown.
Effects on the development of Plasmodium berghei
Three Plasmodium berghei challenge experiments were conducted
on transiently Wolbachia-infected A. gambiae females compared to
buffer injected, uninjected, and in one case E. coli-injected controls
(Figure 3a–c). In all three experiments highly significant reductions
in intensity of oocyst infection in the wMelPop transinfected
females were observed compared to the other treatments, while
there were no significant differences between any of the control
treatments within each experiment. Mean P. berghei intensities were
reduced in the wMelPop-infected mosquitoes by between 75% and
84% compared to the corresponding buffer injected control
groups. A further experiment confirmed the lack of any significant
differences in intensity between the E. coli-injected, buffer injected
and uninjected controls (data not shown).
In order to obtain evidence for a causal link between the
immune upregulation and the Plasmodium inhibition phenotypes,
TEP1 knockdown was undertaken by injection of dsRNA at the
same time as Wolbachia injection. Significantly higher oocyst
numbers were observed compared to the control where dsLacZ
was injected at the same time as Wolbachia (Figure 3d). This
experiment provides evidence for a significant contribution of
Wolbachia-induced TEP1 upregulation to the Plasmodium inhibition
phenotype.
Utility of transient somatic wMelPop infections
We assessed the utility of the transient wMelPop somatic
infection model by comparing the effects on host immunity and
pathogen development with those observed in stable inherited
infections of wMelPop. To do this we utilized a filarial nematode-
susceptible line of another mosquito species, Ae. aegypti, in which
we have previously carried out Brugia pahangi challenges on a stable
wMelPop-transinfected line [7,12]. We created somatic wMelPop
infections using exactly the same methodology as carried out for
An. gambiae, and after eight days challenged them with B. pahangi or
carried out qRT-PCR.
The somatic Wolbachia infection also induced upregulation of
selected immune genes (PGRPS1, CECD, CLIPB37, CTL) (Figure 4a).
The scale of upregulation was considerably lower than observed in the
comparable Ae. aegypti stable transinfection as previously reported [12].
Likewise, challenge of the somatically wMelPop infected females with
B. pahangi did produce a significant reduction in the numbers
developing to the L3 (infectious) stage compared to the controls
(Figure 4b), as was previously observed in the stable inherited wMelPop
infected line, which showed.50% reduction in mean numbers of L3
compared to theWolbachia-uninfected control at the same microfilarial
challenge density [12]. Using quantitative PCR comparing three
groups of two mosquitoes with the single copy genes ftsZ (Wolbachia)
and Actin5C (Ae. aegypti) for normalization, we estimated that there were
approximately 176670 times more wMelPop cells in the stably
infected line compared to the somatic infections. This may explain this
reduced effect on gene upregulation. Therefore we conclude that
intrathoracic inoculation can be a valuable way to test the effects of
Wolbachia on host immunity and pathogen transmission. Although
extrapolations to different mosquito species and parasites must be
made with care, it does seem likely that the effects observed for somatic
Wolbachia infections using the methodology reported here are likely to
be smaller than for a stable inherited infection, and thus that the
estimations made may be conservative.
An experiment to test whether the immune upregulation
observed in wMelPop-infected mosquitoes affects the density of
the Wolbachia itself was conducted using the stable inherited
infection of wMelPop in an Ae. aegypti Refm background [7,12].
Wolbachia ftsZ gene expression (used as a proxy for Wolbachia
density) was found to be higher in dsRel2-injected than in dsLacZ-
injected mosquitoes at both day six and day ten post-injection
(Figure 4c). These data suggest that the immune effectors
controlled by the Imd (Rel2-controlled) pathway can influence
Wolbachia densities. The very high rate of maternal transmission
observed in wMelPop-infected Ae. aegypti [7], despite chronic
immune upregulation, means that the biological significance of
this density difference is unknown, although potentially it could act
to limit wMelPop pathogenicity to some degree. More compre-
hensive experiments addressing this question will make use of
transgenic immune knockdown lines infected with wMelPop,
which are currently being produced, and are expected to enable
the effects of stronger and more long lasting immune pathway
knockdown to be investigated.
Discussion
The data reported strongly support the hypothesis that
wMelPop can inhibit the development of Plasmodium in Anopheles
Figure 2. Immune gene expression in the An. gambiae wMelPop-infected MOS55 cell line. The expression of six immune genes as
described for Figure 1 were analyzed by qRT-PCR, for the An. gambiae MOS55 cell culture infected with wMelPop, normalized to expression of these
genes in a tetracycline treated, wMelPop free, genetically identical, MOS55 cell culture. Three samples of cells were taken from the cultures at
different times; error bars show the SEM of these three samples.
doi:10.1371/journal.ppat.1001143.g002
Wolbachia and Malaria
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malaria vector mosquitoes. The An. gambiae/P. berghei combination,
although not one that occurs in nature, does represent a tractable
and well studied model for which considerable information is
already available about Plasmodium killing mechanisms; however
we recognize the challenge experiments will ultimately need to be
repeated with the far less tractable human parasite P. falciparum
once a stably inherited Wolbachia transinfected line of An. gambiae
has been created. The densities of P. berghei used in laboratory
challenges such as these can be high compared to those of P.
falciparum that would occur in nature, although the mean
intensities recorded in these studies lie within the range recorded
for P. falciparum in the field. The significant reductions in intensity
we recorded in laboratory experiments are considered likely to
translate to significant reductions in oocyst prevalence/transmis-
sion in a real-life setting.
The knockdown experiment provided evidence for a major role
of TEP1, and by extension LRIM1 whose products interact as part
of the same opsonization pathway [20], in the inhibition of P.
berghei development. This is the first time a direct link between the
Wolbachia pathogen inhibition and immune upregulation pheno-
types has been made. A more detailed and exhaustive investigation
of the relative contributions of different components of the
Anopheles immune system to Plasmodium killing can be made once
stable inherited Wolbachia infections have been established.
Taken together with the recent report of reduction in P.
gallinaceum development in wMelPop-infected Ae. aegypti [21], the
Figure 3. An. gambiae somatically infected with wMelPop: challenges with Plasmodium berghei. Each panel represents an independent
experiment showing mean numbers of oocysts per midgut (parasite intensities), comparing An. gambiae challenged with P. berghei eight (A–C) or five
(D) days after intrathoracic innoculation with, in A–C, Wolbachia wMelPop compared to buffer (BI) and non-injected (NI) controls plus in C E. coli (EI);
and in (D) Wolbachia+dsLacZ (WLI), Wolbachia+dsTEP1 (WTI) and NI. Parasite survival was determined by oocyst counting on day 10 post infection. In
A–C significant reductions in intensity were observed in WI females compared to the NI, BI and EI controls: ***P,0.001; ** P,0.01. P. berghei
prevalence was also significantly reduced (P,0.05) in WI compared to one or more of the controls: expt. A. NI = 78.5% (33/42); BI = 81.8% (27/33),
WI = 60.0% (27/45); expt. B NI = 88.4% (23/26), BI = 92.3% (12/13), WI = 57.1% (12/21; expt. C NI = 90.3% (28/31), BI = 96.0% (24/25), WI = 63.1% (12/19),
EI = 81.2% (13/16). In experiment D intensity was significantly lower in the WLI group compared to WTI and NI, *P,0.05. Prevalence was 81% (39/48)
for NI, 81% (13/16) for WTI and 50% (6/12) for WLI.
doi:10.1371/journal.ppat.1001143.g003
Wolbachia and Malaria
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Figure 4. Immune gene expression and challenges with Brugia pahangi in Ae. aegypti somatically infected with wMelPop, and effects
of immune knockdown onWolbachia density. A) The expression of four immune genes were analyzed by qRT-PCR: a peptidoglycan recognition
Wolbachia and Malaria
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data increase the desirability of creating stably inherited wMelPop
transinfections in important malaria vectors. The potential
combination of lifespan shortening and direct inhibition of
Plasmodium development in the mosquito would represent a very
attractive control strategy, since both of these phenotypes are
critical components of malaria vectorial capacity. A simple model
exploring relative contributions of these two parameters to
vectorial capacity is shown in Figure 5. Though lifespan reduction
and Plasmodium inhibition can each substantially reduce the
vectorial capacity of a mosquito population, together they act
synergistically to reduce transmission. Depending on the scale of
lifespan reduction that would be observed under field conditions,
which is as yet unknown, the Plasmodium inhibition effect could
dramatically increase the efficacy of the wMelPop infection in
reducing malaria transmission.
Other Wolbachia strains might also show malaria inhibition
effects, particularly if they reach high somatic densities and/or
induce large-scale immune stimulation. Here we show that the use
of transient somatic infections of Wolbachia by adult female
inoculation followed by pathogen challenge is a valuable means to
test likely effects on immunity and transmission. This is significant
as it allows comparison and selection of strains for the most
desirable properties prior to the lengthy, and technically very
challenging, process of creating stably inherited Anopheles transin-
fections. If other Wolbachia strains can be identified which also
inhibit Plasmodium transmission, they would represent an attractive
alternative to wMelPop if they do not shorten lifespan to the same
extent, since they are therefore likely to have much lower fitness
costs. Only the wMelPop strain has to date been found to produce
a strong life-shortening phenotype.
Laboratory estimates suggest that transinfection of wMelPop in
Aedes aegypti can reduce fitness by around 50% [7]. This would appear
to make it difficult for this strain ofWolbachia to spread by means of CI
through natural populations [26], particularly where populations are
fragmented. However, fitness estimates made in relatively benign
laboratory conditions, where a comparatively large fraction of the
population become old, can overestimate the relative costs of infection.
In the field most mosquitoes die early and few live long enough to
experience higherWolbachia-induced mortality (although those that do
are significant to disease control, if they would otherwise have lived
long enough to transmit the infection). As shown in Figure 5
reductions in longevity and Plasmodium inhibition together determine
vectorial capacity and it will also be important to understand the joint
effects of the two phenotypes on mosquito fitness in the field. Detailed
knowledge of the demographics of the target species is also important
[27]. Selective pressures acting on the host would likely modulate the
life-shortening phenotype over time, but this may not occur rapidly
enough to prevent a sustained period of disease control.
Wolbachia is now known to inhibit the dissemination or
development of a variety of insect pathogens and insect-borne
pathogens – various Drosophila pathogenic viruses, dengue and
chikungunya viruses of humans, and filarial nematode parasites in
addition to Plasmodium [12,21,28–31]. Some of these pathogen-
inhibition phenotypes have been reported in Drosophila species that
naturally harbour Wolbachia, in other words they are not restricted
to species such as Ae. aegypti or An. gambiae in whichWolbachia forms
a novel transinfection. On a broader level these Wolbachia cases
can be added to various other examples where bacterial symbionts
have been shown to provide protective effects against one or more
pathogens [32,33], although the mechanisms involved are likely to
be diverse. Parallels can also be drawn with the effects of
entomopathogenic fungi, which can both reduce Anopheles lifespan
and directly inhibit Plasmodium development [34–36]. Pathogen
inhibition represents a new and increasingly significant component
of our understanding of the effects of Wolbachia in insects, and
provides excellent prospects for the development of novel malaria
control strategies.
Materials and Methods
Ethics statement
All procedures involving animals were approved by the ethical
review committee of Imperial College and by the United Kingdom
Figure 5. Model of possible effects of wMelPop on malaria
vectorial capacity. Vectorial capacity is a measure that describes the
transmission potential of a mosquito population and is independent of
Plasmodium prevalence. It can be thought of as proportional to the
number of infectious bites that occur per day after a single infectious
human arrives in a previously malaria-free area. If we assume
recruitment to the adult mosquito stage is constant then vectorial
capacity can be written (A b (12m)t)/m where b is the ability of the
mosquito to transmit Plasmodium, m is adult daily survival, t is the
length of the intrinsic incubation period of the Plasmodium and all
other parameters are combined in A [42]. The figure plots vectorial
capacity as transmission (b) and daily survival (m) are each reduced
because of the presence of Wolbachia by a multiplicative factor (12x)
where x varies in the range 0 to 1 (parameters: b= 1; m= 0.1; t= 1; A= 1).
A more advanced analysis tailored to a specific system might want to
include age-specific adult mortality, the effect of Wolbachia on
mosquito population dynamics and seasonality.
doi:10.1371/journal.ppat.1001143.g005
protein, PGRPS1; cecropin D, CECD; CLIP-domain serine protease, CLIPB37; and a C-type galactose-specific lectin. Adult females were injected with
wMelPop or the buffer alone, approximately seven days post-eclosion. RNA was extracted from these adults eight days after injection. Expression was
normalized to non-injected adult females of the same age from the same colony. Error bars show the SEM of three biological replicates, each
containing eight adult females (total of 24 mosquitoes per condition). B) The mean numbers of L3 stage (infective) larvae per mosquito are shown
following B. pahangi challenge in Ae. aegypti Refm strain previously injected with wMelPop or buffer; * P,0.05. Numbers above bars show the
prevalence of filarial infection as a proportion of mosquitoes that contained at least one L3 Brugia larva over the total number of mosquitoes
dissected in each category. C) We measured the levels Wolbachia ftsZ gene expression as a proxy for Wolbachia density and normalized the qRT-PCR
data to the mosquito Actin5C gene. Two sets of three females per time point injected with either dsLacZ or dsRel2 were assayed. ftsZ gene expression
was found to be higher in dsRel2-injected mosquitoes than in dsLacZ-injected mosquitoes at both six and ten days post injection. The mean level of
Rel2 transcript in dsRel2-injected mosquitoes was confirmed to be approximately 40% of that in dsLacZ injected mosquitoes at both time points.
These data suggest that the immune effectors controlled by the Imd pathway (Rel2-controlled) can influence Wolbachia densities.
doi:10.1371/journal.ppat.1001143.g004
Wolbachia and Malaria
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Government (Home Office), and were performed in accordance
with United Kingdom Government (Home Office) and EC
regulations.
Somatic wMelPop infections
Wolbachia wMelPop was purified from the infected An. gambiae
cell line MOS55 [22,37] as previously described [23,24]. This
protocol has previously been shown to allow Wolbachia replication
in the recipient An. gambiae [24]. Cells obtained from one 75 CM2
flask were re-suspended in 100 mL of Schneider medium without
antibiotics (optical density, OD=0.09). 69 nL of this Wolbachia
suspension (or 69 nL Schneider for the controls) were microin-
jected into the thorax of young An. gambiae females of the G3 strain
or Ae. aegypti females of the Refm strain [38] using an Nanoject
microinjector (Drummond). The mosquitoes were supplied with
10% sucrose ad libitum and left to recover for at least eight days
prior to qRT-PCR or challenge experiments. A similar OD of 0.1
for E. coli was used to inject another set of controls.
qRT-PCR and qPCR
Gene expression levels were monitored using qRT-PCR. Total
RNA was extracted with Trizol reagent from groups of ten An.
gambiae or Ae. aegypti females maintained at 26uC and 70% relative
humidity, and cDNAs were synthesised from 1 mg of total RNA
using SuperScript II enzyme (Invitrogen). qRT-PCR was
performed on a 1 to 20 dilution of the cDNAs using dsDNA dye
SYBR Green I. Reactions were run on a DNA Engine
thermocycler (MJ Research) with Chromo4 real-time PCR
detection system (Bio-Rad) using the following cycling conditions:
95uC for 15 minutes, then 45 cycles of 95uC for 10s, 59uC for 10s,
72uC for 20s, with fluorescence acquisition at the end of each
cycle, then a melting curve analysis after the final one. The cycle
threshold (Ct) values were determined and background fluores-
cence was subtracted. Gene expression levels of target genes were
calculated, relative to the internal reference gene Actin5C or RS17
for Ae. aegypti and RS7R for An. gambiae. Primers were designed
using Vectorbase (www.vectorbase.org) mosquito gene sequences/
orthology criteria, and the wMel genome sequence [39], since
wMel and wMelPop are closely related [40]. Primer pairs used to
detect target gene transcripts are listed in Table 1.
The density of Wolbachia in somatic and stable infections of Ae.
aegypti was estimated using both qPCR and qRT-PCR. DNA was
extracted using the Livak method and qRT-PCR or qPCR
equipment and protocols were the same as those described above.
The single copy genes ftsZ (Wolbachia) and Actin5C and S7 (Ae.
aegypti) were used to estimate relative numbers of Wolbachia
normalized against the mosquito genome.
Plasmodium berghei challenge experiments
General parasite maintenance was carried out as previously
described [41]. P. berghei ANKA 2.34 parasites were maintained in
4–10-week-old female Theiler’s Original (TO) mice by serial
mechanical passage (up to a maximum of eight passages). Hyper-
reticulocytosis was induced 2–3 days before infection by treating
mice with 200mL i.p. phenylhydrazinium chloride (6mg/ml in
PBS; ProLabo UK). Mice were infected by intraperitoneal (i.p.)
injection and infections were monitored on Giemsa-stained tail
blood smears.
Table 1. Oligonucleotide primers used in quantitative PCR experiments and dsRNA synthesis.
Gene Name Accession no. Forward Primer Reverse Primer
An. gambiae
CEC1 AGAP000693 CCAGAGACCAACCAACCACCAA GCACTGCCAGCACGACAAAGA
DEF1 AGAP011294 CATGCCGCGCTGGAGAACTA GATAGCGGCGAGCGATACAGTGA
LRIM1 AGAP006348 CATCCGCGATTGGGATATGT CTTCTTGAGCCGTGCATTTTC
TEP1 AGAP010815 CGCCCAGGAGCGTACGTTGG CCTGGCGAACAGACCCAAGCTG
CTL4 AGAP005335 ATCGGAATGTCGATCGCTAC CTGTCCGGCGATCAAACTAT
CLIPB3 AGAP003249 CAGATTGTCGTCCACACTGG GCTCAGGGGCAGACAGATAG
RS7R AGAP010592 AGAACCAGCAGACCACCATC GCTGCAAACTTCGGCTATTC
dsRNA-Tep1 [17] AGAP010815 TAATACGACTCACTATAGGGTTTGTGGGCCTTAAAGCGCTG TAATACGACTCACTATAGGGACCACGTAACCGCTCGGTAAG
Ae. aegypti
PGRPS1 AAEL009474 TGGAGCGACATTGGTTACAA GCGATGCCAATCGACTTACT
CECD AAEL000598 GCTAGGTCAAACCGAAGCAG TCCTACAACAACCGGGAGAG
CLIPB37 AAEL005093 TTGGGGGAAAACAGAAACAG GATCTGCTTCCCAGAGAACG
Galactose-specific CTL AAEL005641 GTCTCCGGGTGCAATACACT CCCTATCGTTCCACTTCCAA
Actin5C AAEL011197 ATCGTACGAACTTCCCGATG ACAGATCCTTTCGGATGTCG
RpS17 AAEL004175 CAGGTCCGTGGTATCTCCAT CAGGACATCATCGAAGTCGA
Rel2 [43] AAEL007624 GGACGAGGCAGCGGCGCAGTTTGAGC TCCAGAGGGCCGAGATAAGTTCC
dsRNA-Rel2 [43] AAEL007624 TAATACGACTCACTATAGGGACCGGTGGAAGTGCTC TAATACGACTCACTATAGGGCCCCGATCTCCGTTAT
Wolbachia wMel
ftsZ WD_0723 TGATGCTGCAGCCAATAGAG TCAATGCCAGTTGCAAGAAC
E. coli
dsRNA-LacZ EG10527 TAATACGACTCACTATAGGGAGAATCCGACGGGTTGTTACT TAATACGACTCACTATAGGGCACCACGCTCATCGATAATTT
Previously published oligonucleotides are indicated by the reference number following the gene name.
doi:10.1371/journal.ppat.1001143.t001
Wolbachia and Malaria
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In four independent experiments, individual 4–10 week old
Theiler’s Original (TO) mice were treated with 200mL i.p.
phenylhydraziuium chloride (PH; 6mg/ml in PBS; ProLabo
UK) to induce hyper-reticulocytosis. Three days later mice were
injected by intraperitoneal (i.p.) injection with 106 parasites of P.
berghei ANKA 2.34 as described previously [41]. Three days post
mouse infection, batches of 100 starved Anopheles gambiae strain G3
females, eight days post injection with Wolbachia, buffer, E. coli or
uninjected controls, were allowed to feed on the infected mice. 24h
after feeding, mosquitoes were briefly anesthetized with CO2, and
unfeds removed. Mosquitoes were then maintained on fructose
[8% (w/v) fructose, 0.05% (w/v) p-aminobenzoic acid] at 19–
22uC and 50–80% relative humidity. At day 10 post-feeding,
mosquito midguts were dissected, and oocyst numbers (intensity)
and prevalence recorded. The Kruskal-Wallis test was used to
compare oocyst counts (intensity of infection) and Fisher’s exact
test for prevalence (percentage of mosquitoes containing at least
one oocyst).
Gene knockdown experiments
T7-tailed primers (see Table 1) were used to amplify fragments
of the TEP1 and REL2 gene from female cDNA template or the
LacZ gene from E. coli total DNA. dsRNA was synthesized using
the T7 Megascript kit (Ambion) and adjusted to a concentration of
3 or 4 mg/ml in RNAse free water for dsREL2 and dsTEP1
respectively. For REL2 KD 69nl of dsRNA were injected per
female mosquito, For TEP1-wolbachia KD 69 nl of a mix of 2
parts dsRNA to 1 part of purified wMelPop in Schneider’s
medium (OD 0.3) were injected into the thorax of CO2
anesthetized female An. gambiae mosquitoes (total ,200 per group).
Five days after injection (in order to still fall within the gene
knockdown period), mosquitoes were fed on a Plasmodium infected
mouse.
Brugia pahangi filarial nematode challenge
Ae. aegypti mosquitoes of the filaria-susceptible Refm strain were
fed on sheep blood containing 23 B. pahangi microfilaria per mL
eight days post Wolbachia innoculation, plus buffer-injected
controls of the same age; any females that did not feed properly
were removed. Dissections were carried out 10 days after the
infective blood meal under a dissecting stereomicroscope. Kruskal-
Wallis tests were used to compare counts of B. pahangi L3 (infective
stage larvae).
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